[-] Show simple item record

dc.contributor.authorSturpe, Deborah A.eng
dc.contributor.authorMertens, Marsha K.eng
dc.contributor.authorScoville, Caryneng
dc.date.issued2002eng
dc.description.abstractSubstituting bupropion, nefazodone, or mirtazapine is beneficial. (Grade of recommendation: B, randomized controlled trials [RCTs].) Augmentation therapy with amantadine, bupropion, and buspirone is no better than placebo. (Grade of recommendation: B, RCTs.) Augmentation therapy with multiple other agents may be beneficial. (Grade of recommendation: D, open-label nonrandomized studies, case series, and case reports.) SSRI "drug holidays" may also be effective. (Grade of recommendation: D, open-label nonrandomized studies.)eng
dc.identifier.urihttp://hdl.handle.net/10355/2877eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofcollectionClinical Inquiries, 2002 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri--Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.relation.ispartofseriesJournal of family practice, 51, no. 08 (August 2002)eng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectdrug holidayseng
dc.subjectaugmentation therapyeng
dc.subject.lcshSexual disorderseng
dc.subject.lcshImpotence -- Chemotherapyeng
dc.titleWhat are the treatment options for SSRI-related sexual dysfunction?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record